Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Megan Baldwin, CEO, Opthea Ltd
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Opthea with Proactive at the ASX Small and Mid-Cap Conference
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
SolGold: Positive Investor Feedback and Promising Regional Exploration at One-to-One Mining Conference
00:10:00
Keith Farlinger on BDO's Global Vision: People Helping People Achieve Their Dreams | Keith Farlinger, CEO , BDO Global.
00:10:00
Northern Ontario Mining Showcase: Uniting SMEs for Global Opportunities | Patty Hajdu - Minister of Northern Ontario Mining Showcase
00:10:00
Q3 2024 Earnings GTM strategy | Samuel Wilson, CEO, 8x8 IncEGHT:NSQ
00:10:00
Discussion on the Post-Pandemic Business Landscape with Nordic Capital's COO | Klas Tikkanen , COO, Nordic Capital.
00:10:00
A Strategic Growth Pillar for Fill Invest Development Group's Diversification Strategy| Josephine Gotianun Yap , CEO, Filinvest Development Corp.
00:10:00
Establishing a Strong Financial Plan in 2021: A Post-Pandemic Priority
00:10:00
American Eagle Gold Reports Exciting New Drilling Results and Expands Exploration Program
00:10:00
"November 2022 Investment Committee Update with John Shanley, CFP®, and Dan Ballou, CFP® | Connecticut Wealth Management"
00:10:00
Addressing the Gender Pay Gap in Financial Services with Drs. Tharp, Lurtz, & Mielitz | Daniel Yerger - President of MY Wealth Planners
00:10:00
Early-stage venture fund and incubator that founds and funds transformative companies|Kevin Ryan,Founder and CEO,AlleyCorp
00:10:00
Nathan Lead, Senior Analyst at Morgans, reviews Atlas Arteria as a new addition to Morgans Best Ideas (November 2021).|Graeme Bevans is an Executive Director of ATLAX